Center-Authored Papers

Filters: Author is Chow, Laura Q  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Baik CS, Chamberlain MC, Chow LQ.  2015.  Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
S
Seiwert TY, Burtness B, Mehra R, Weiss J, Berger R, Eder JP, Heath K, McClanahan T, Lunceford J, Gause C et al..  2016.  Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.. The Lancet. Oncology. Abstract
P
Chow LQ, Santana-Davila R, Pantel A, Roth M, Anderson LN, Failor A, Doot R, Mankoff D.  2017.  A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.. PloS one. 12(6):e0178325. Abstract
N
Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E et al..  2015.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.. The New England journal of medicine. Abstract
Hellmann MD, Rizvi NA, Goldman JW, Gettinger SN, Borghaei H, Brahmer JR, Ready NE, Gerber DE, Chow LQ, Juergens RA et al..  2016.  Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.. The Lancet. Oncology. Abstract
Gettinger S, Rizvi NA, Chow LQ, Borghaei H, Brahmer J, Ready N, Gerber DE, Shepherd FA, Antonia S, Goldman JW et al..  2016.  Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(25):2980-7. Abstract
Rizvi NA, Hellmann MD, Brahmer JR, Juergens RA, Borghaei H, Gettinger S, Chow LQ, Gerber DE, Laurie SA, Goldman JW et al..  2016.  Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Lee SM, Chow LQ.  2014.  A new addition to the PD-1 checkpoint inhibitors for non-small cell lung cancer-the anti-PDL1 antibody-MEDI4736.. Translational lung cancer research. 3(6):408-10.
E
Baik CS, Pritchard CC, Eaton KD, Chow LQ.  2013.  EGFR mutations in squamous cell lung cancer in never-smokers.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 8(1):e6-7.
C
Dietsch GN, Lu H, Yang Y, Morishima C, Chow LQ, Disis ML, Hershberg RM.  2016.  Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.. PloS one. 11(2):e0148764. Abstract